StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note published on Saturday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE CO opened at $1.25 on Friday. The firm has a market cap of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50. The company’s 50-day simple moving average is $1.51 and its 200-day simple moving average is $1.36.
About Global Cord Blood
Further Reading
- Five stocks we like better than Global Cord Blood
- 3 Warren Buffett Stocks to Buy Now
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Merger or Not, Albertson’s Companies is a Good Buy
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.